Akbar Group: Extracellular Vesicles in Cardiovascular, Inflammatory and Metabolic Disease
The Akbar Lab is interested in defining the therapeutic and diagnostic potential of extracellular vesicles for immunomodulation and precision medicine in cardiovascular, metabolic, and inflammatory diseases.
We have a particular interest in how endothelial cell derived extracellular vesicles mediate long range communication across organs, and how we can capitalise on this signalling for targeted therapeutics and diagnosis. We employ state of the art techniques in extracellular vesicle isolation and characterisation, using translational approaches of highly characterised clinical cohorts to derive hypothesis driven in vitro and in vivo studies using model systems.
DPhil Students
Current
Dann Paget
Lewis Timms
Amaury Genovese
Complete
2019 Laurienne Edgar
Masters Students
Current
Amber Wilkins
Undergraduate Final Honours School Students
Current
Divya Ganesh
Complete
2022 Raphaella Ridley
2019 Charlotte Lee
2018 Jonathan Martin
2018 Eleanor Hogg
2017 Tanvir Rafe
Latest publications
-
Reassessing the association: evaluation of a polyalanine deletion variant of RUNX2 in non-syndromic sagittal and metopic craniosynostosis
Journal article
Walton I. et al, (2024), Journal of Anatomy
-
Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells.
Journal article
Barnkob MB. et al, (2024), Nat Commun, 15
-
Plasma fibrinogen and risk of vascular recurrence after ischaemic stroke: An individual participant and summary-level data meta-analysis of 11 prospective studies.
Journal article
McCabe JJ. et al, (2024), Eur Stroke J
-
Recommendations for quantitative cerebral perfusion MRI using multi‐timepoint arterial spin labeling: Acquisition, quantification, and clinical applications
Journal article
Woods JG. et al, (2024), Magnetic Resonance in Medicine